Business Wire

Semperis Brings Award-Winning Hybrid Identity Protection Conference to Europe, Keynotes Announced

12.5.2021 11:00:00 EEST | Business Wire | Press release

Share

Semperis, the pioneer in identity-driven cyber resilience for enterprises, today announced that it will host the inaugural Hybrid Identity Protection (HIP) Europe Virtual Conference 2021, taking place virtually on 30 June and 1 July 2021. The first European edition of the award-winning global Hybrid Identity Protection conference series, HIP Europe will bring together leading experts working at the intersection between identity and security to provide a deep dive into the latest trends and challenges in managing hybrid and multi-cloud environments.

Keynote speakers will include Microsoft MVP Tony Redmond, aka the Exchange Godfather and author of numerous books and blogs on Microsoft Exchange and Office 365, and Microsoft Directory Services MVP and identity guru John Craddock, who has played a key role architecting identity and security solutions for industry leaders including Microsoft, the UK Government and multi-national businesses.

Organisations globally are struggling to keep up with the skyrocketing proliferation of cyberattacks — including the infamous SolarWinds supply-chain attack and the Hafnium attack on Microsoft Exchange — that target identity systems, especially Active Directory. HIP Europe will connect technology gurus and practitioners in an environment where they can exchange information, share war stories, and ultimately make their networks and applications more secure.

The HIP conference has earned its place as the premier educational forum for identity-centric cybersecurity leaders tasked with defending hybrid environments. First established in the US and now coming to Europe, the conference series is designed to advance the skills of IT and cybersecurity professionals through highly technical demonstrations, expert roundtables, and networking sessions. Attendees will learn best practices from local identity and access management (IAM) experts and Microsoft Most Valuable Professionals (MVPs), and connect with peers facing similar infrastructure and security challenges.

Agenda highlights

The two-day conference programme is packed with actionable insights for practitioners, from discussing the future of cloud security to identifying and recovering from directory breaches and cyber disasters. Highlights include:

  • The Future of Microsoft Cloud Services. In this keynote session, Tony Redmond will look at the economics, software engineering, ecosystem and landscape of Microsoft 365 and discuss the reliability and security of Office 365.
  • The Future of Identity: DIDs and VCs. This keynote by John Craddock will be an introduction to the future of identity with Decentralised Identifiers (DIDs) and Verifiable Credentials (VCs). What if users owned their identity without dependence on identity providers and only needed to prove who they are once, using that proof as often as necessary?
  • Cloud Security: What’s Next? Providing a simple and unified hybrid security management engine that spans the heterogeneous space of on-premises, shared data centre and cloud is a key challenge. This session will sketch the current cloud security landscape and what challenges lie ahead for hybrid organisations.
  • Deploying a Zero Trust Infrastructure. This session will demonstrate how to implement the principles of Zero Trust within a Microsoft hybrid cloud infrastructure, building on the Microsoft security stack with Azure AD, Control and Conditional Access Management features and Microsoft 365 Defender suite.

Keynote speaker and identity guru John Craddock comments: “Almost all organisations consume services from the cloud and are possibly shifting their own services to the cloud, building valuable collaborative environments providing access for their users, partners and consumers. The security boundary stretches and morphs as we create these new hybrid systems. With these elastic boundaries, identity becomes the critical component in securing our assets and managing access control. At the Hybrid Identity Protection conference, attendees can learn from industry leaders how to identify potential vulnerabilities and protect their systems for the future. A paradigm shift is around the corner with Decentralised Identity and Verifiable Credentials. My keynote will explain the benefits of this exciting new technology.”

Guido Grillenmeier, Chief Technologist at Semperis and Microsoft MVP alumnus for Directory Services, adds: “We’re excited to bring the HIP conference to Europe for the first time. It promises an amazing line-up of the world’s foremost hybrid identity experts covering today’s hottest identity security topics: the future of cloud services, cloud security and identity itself. Zero Trust is the name of the game when it comes to preventing malicious actors from stealing the keys to your kingdom – your most privileged accounts – be it on-premises or in the cloud. HIP Europe will give solid insights into how it is done right. Due to the pandemic, this will be a fully virtual experience, and it is free to attend. Security professionals can expect to discuss learnings from recent cyber incidents, experiences in recovering from attacks and how to defend modern environments against emerging threats.”

The global HIP event was established by Semperis in 2016 and has won several awards, including the 2021 Globee Business Awards – Gold Winner, Achievement of the Year in Live Events, the 2020 Cybersecurity Excellence Awards – Best Cybersecurity Conference, the Golden Bridge Business and Innovation Awards – Gold Winner, Live Event of the Year, and the 2020 IT World Awards – Bronze Winner, Security Awareness Computer-Based Training.

HIP Europe attendees can qualify for up to 12 continuing professional education (CPE) credits.

The full conference agenda is available: https://www.accelevents.com/e/HIPEurope#agenda

Registration is free: https://www.accelevents.com/e/u/checkout/HIPEurope/tickets/order

About Hybrid Identity Protection

Mobile workforces, cloud applications and digitalisation are changing every aspect of the modern enterprise. And with radical transformation come new business risks. Hybrid Identity Protection (HIP) is the premier educational forum for identity-centric practitioners. Whatever industry sector or job function, HIP strives to provide its community the insights and relationships needed to enable and protect today’s digitally driven organisations.

Twitter https://twitter.com/HIPConf
LinkedIn https://www.linkedin.com/company/hybrid-identity-protection-conference/
Facebook https://www.facebook.com/HIPConf/

About Semperis

For security teams charged with defending hybrid and multi-cloud environments, Semperis ensures integrity and availability of critical enterprise directory services at every step in the cyber kill chain and cuts recovery time by 90%. Purpose-built for securing Active Directory, Semperis’ patented technology protects over 40 million identities from cyberattacks, data breaches, and operational errors. The world’s leading organisations trust Semperis to spot directory vulnerabilities, intercept cyberattacks in progress, and quickly recover from ransomware and other data integrity emergencies. Semperis is headquartered in New Jersey and operates internationally, with its research and development team distributed between San Francisco and Tel Aviv.

Semperis hosts the award-winning Hybrid Identity Protection conference (www.hipconf.com). The company has received the highest level of industry accolades and was recently ranked the fourth fastest-growing company in the tri-state area and 35th overall in Deloitte’s 2020 Technology Fast 500™. Semperis is accredited by Microsoft and recognised by Gartner.

Twitter https://twitter.com/SemperisTech
LinkedIn https://www.linkedin.com/company/semperis
Facebook https://www.facebook.com/SemperisTech
YouTube https://www.youtube.com/channel/UCycrWXhxOTaUQ0sidlyN9SA

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Paula Averley
Origin Communications
E. semperis@origincomms.com
T. +44 (0)20 3814 2940

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye